GSK Plc ADR

GSKNYSE · USD
47.76USD0.00 (-0.13%)
797

GSK Plc ADR (GSK) Covered Calls

GSK Plc ADR trades in the Drug Manufacturers - General industry with an IV Rank of 86.51%, high versus the past year. GSK's highest covered call setup is the $51.00 strike expiring Dec 4, 2026, sorted by theoretical annualized return. It's 6.78% out of the money with 14 days to expiration, a 6.89% return until expiration, and a 179.60% theoretical annualized return. Across the setups shown, annualized returns run from 72.81% to 179.60% at strikes between $49.50 and $70.00, with 14 to 182 days to expiration, as of Nov 20, 2026.

Read more

Running GSK covered calls helps you generate income from GSK Plc ADR shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best GSK covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If GSK stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling GSK covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given GSK covered call is worth writing.

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections.

2026-12-041451.006.780.050.95329.006.89179.60-0.10+0.23480.90
2026-12-112151.006.780.150.65339.007.10123.37-0.31+0.21340.50
2027-02-199160.0025.630.100.401234.0025.84103.63-0.21+0.082440.30
2027-01-155655.0015.160.150.75739.0015.47100.85-0.31+0.152,0720.60
2026-12-041449.503.640.051.35179.003.7597.71-0.10+0.3301.30
2027-05-2118270.0046.570.050.402229.0046.6793.60-0.10+0.0680.35
2026-12-112150.004.690.300.60254.005.3292.44-0.63+0.26250.30
2026-12-243451.006.780.351.10359.007.5280.69-0.73+0.27270.75
2026-12-182850.004.690.501.00274.005.7474.79-1.05+0.312,0500.50
2027-05-2118265.0036.100.100.551734.0036.3172.81-0.21+0.08490.45

As of Nov 20, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryDrug Manufacturers - General
  • SectorHealthcare
  • IV Rank86.51% High
  • Market cap (M$)95,733
  • 52 weeks high-22.59%
  • 52 weeks low4.23%
  • Analyst recommendationBuy
    2.00
  • Target price$56.57
    18.45% above the current stock price
  • Dividend—
  • Payout ratio46.93%
  • Earnings date2027-02-03
  • P/E16.65
  • Future P/E9.61
  • EPS (ttm)2.87
  • EPS growth next 5 years3.53%

As of Nov 20, 2026